FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation
Open Access
- 1 December 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 25 (12) , 2397-2405
- https://doi.org/10.1093/carcin/bgh250
Abstract
Our aim was to study the anticancer effect of the novel immunomodulator FTY720 in vitro and in vivo by investigation of cell cycle entry, cell cycle regulation, cell survival and apoptosis pathways. Three hepatoma cell lines with different p53 statuses (HepG2, Huh-7 and Hep3B) and one non-tumorigenic immortalized liver cell line (MIHA) were used for an in vitro study. The in vivo effects of FTY720 were evaluated in a nude mouse tumor model. Cell cycle distribution and cell cycle regulator proteins p27 Kip1 and cyclin D1, together with the PI3-K/Akt pathway, mitogen-activated protein kinases and cleaved caspase-3 and caspase-9, were evaluated. FTY720 selectively induced cell apoptosis in hepatoma cell lines with overexpression of cleaved caspase-3 and caspase-9, but the same phenomena were not found in MIHA cells. FTY720 induced Akt dephosphorylation at Ser473 mediated by phosphoinositide 3-kinase (PI3-K) inhibition. Dephosphorylation led to down-regulation of p42/p44 and dephosphorylation of Forkhead transcription factor and GSK-3β and, subsequently, up-regulation of p27 Kip1 and down-regulation of cyclin D1. In our in vivo model FTY720 induced apoptosis of tumor cells by down-regulation of the Akt pathway. FTY720 suppressed tumor growth without notable side-effects in normal liver. In conclusion, FTY720 is a novel anticancer agent that induces apoptosis of hepatoma cell lines both in vitro and in vivo through PI3-K-mediated Akt dephosphorylation in a p53-independent manner.Keywords
This publication has 29 references indexed in Scilit:
- Sphingosine kinase activity is required for sphingosine-mediated phospholipase D activation in C2C12 myoblastsBiochemical Journal, 2004
- OxLDL induces mitogen-activated protein kinase activation mediated via PI3-kinase/Akt in vascular smooth muscle cellsJournal of Lipid Research, 2003
- Induction of Apoptosis in Human Bladder Cancer Cells In Vitro and In Vivo Caused by FTY720 TreatmentJournal of Urology, 2003
- FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cellsTransplantation, 2003
- A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cellsBritish Journal of Pharmacology, 2003
- Hepatocellular carcinoma: is current therapy really altering outcome?Gut, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- The p42/p44 Mitogen-activated Protein Kinase Activation Triggers p27Kip1 Degradation Independently of CDK2/Cyclin E in NIH 3T3 CellsJournal of Biological Chemistry, 2001
- Coordinate Involvement of Cell Cycle Arrest and Apoptosis Strengthen the Effect of FTY720Japanese Journal of Cancer Research, 2001
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978